Latest News
In accordance with Article 13 of Law No. 104-12 on freedom of prices and competition and Article 10 of Decree No. 2-14-652 issued for its implementation, as amended and supplemented, the Competition Council makes available to the public the “summary of the operation” below, containing the information provided by the parties.
This information has been prepared by the notifying parties, who are solely responsible. Any inaccurate or distorted information contained therein does not in any way prejudge the Competition Council’s position on the proposed operation.
The publication of this press release does not confirm the completeness of the file provided for in Article 9 of Decree No. 2-14-652 issued for the implementation of Law No. 104-12 on freedom of prices and competition as amended and supplemented.
Names of the companies and groups concerned:
- The acquirer: The company “Laprophan S.A”;
- The target: The company “Botanic Pharma S.A.R.L”.
Nature of the operation
- Acquisition of exclusive control.
Economic sectors concerned
- Manufacture and marketing of dietary supplements.
Deadline for interested third parties to submit their observations
- 10 days from the date of publication of this press release, i.e. July 1, 2024
NON-CONFIDENTIAL SUMMARY OF THE OPERATION PROVIDED BY THE PARTIES
The Competition Council has received notification of an economic concentration operation concerning the acquisition by the company “Laprophan SA” of the exclusive control of the company “Botanic Pharma SARL” through the acquisition of 75% of its share capital and related voting rights.
“Laprophan S.A” is a Moroccan joint-stock company, active in the pharmaceutical sector and operating in Morocco in the fields of study, research, preparation, manufacturing, distribution, export, import, and trade of medicines.
“Botanic Pharma S.A.R.L” is a Moroccan limited liability company, active in the field of formulation and distribution of dietary supplements, medical devices, and cosmetics.
Done in Rabat, June 20, 2024.
